Authors
Laura Kaori Menegussi Nakano, Thayse Batista Moreira, Ramon de Alencar Pereira, Francisco Augusto Silva Mesquita, Andréa Teixeira-Carvalho, Paulo Guilherme de Oliveira Salles, Marcos Andre Marques Portella, Izabela Ferreira Gontijo de Amorim, Letícia da Conceição Braga
Published in
Acta histochemica. Volume 128. Issue 4. Pages 152381. Nov 14, 2026. Epub Nov 14, 2026.
Abstract
Breast cancer (BC) progression is strongly influenced by the tumor microenvironment (TME). Collagen deposition, a key component of the extracellular matrix, varies across molecular subtypes and influences tumor behavior. Alongside structural changes, cytokines contribute to immune modulation and disease progression. This study investigates the relationship between collagen deposition and serum cytokine profiles in BC. Collagen deposition was quantified in breast cancer tumor tissues from 60 patients using Masson's trichrome staining and digital image analysis, while systemic cytokine levels were measured by multiplex assays in plasma samples from the same 60 patients, followed by statistical and in silico analyses across all molecular subtypes. Collagen deposition decreased with increasing tumor aggressiveness, being highest in early-stage, low-grade tumors and lowest in high-grade and more aggressive tumors, where it showed strong discriminatory capacity. Among systemic immune mediators, only CXCL10 differed across molecular subtypes, with higher levels in Luminal B and Triple-Negative tumors than in HER2 + tumors and moderate diagnostic accuracy. In silico analyses confirmed CXCL10 upregulation in BC and its association with pro-tumorigenic hallmarks. No direct correlation was observed between stromal collagen deposition and circulating CXCL10 levels, suggesting distinct biological mechanisms for these molecules. Despite methodological limitations, this study underscores the value of integrating stromal and immune features in BC characterization with potential relevance for prognostic stratification and future therapeutic strategies.
PMID:
43033750
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0